Clinical trial
Post Marketing Surveillance on the Efficacy, Safety and Tolerability of Linezolid (Zyvox) in the Treatment of Gram Positive Infections
NCT01564758 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance on the Efficacy, Safety and Tolerability of Linezolid (Zyvox) in the Treatment of Gram Positive Infections
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2004
- Completion date
- March 31, 2005
- Enrollment
- 99 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.